Close
ACHEMA MIDDLE EAST 2026

Enhancing Cancer Treatments: The Role of ADCs In Medicine

ADCs could lead to better and more efficient treatments in the complex and specialized field of tailored cancer medicines. ADCs are made up of...

ADCs: From Cancer Treatment To Other Broader Applications

Beyond cancer, there are a number of sectors that provide considerable prospects for antibody drug conjugates (ADCs), using their capacity to deliver therapeutic drugs...

ADCs: Innovations And Market Dynamics In Cancer Therapy

Antibody drug conjugates (ADCs) are the main players in the fields of cancer clinical research and deal-making, with new alliances and contracts appearing on...

Pharmaceutical Water Market: Expected $96.97B Growth By 2033

The pharmaceutical water market is expected to grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2034. It was valued...

Recursion, Exscientia Unite For $850M, 10 Trials In 18 Months

The resultant biotech, which the businesses announced on Thursday, would have a pipeline that may produce 10 clinical readouts over the next 18 months,...

AI Revolutionizes Drug Discovery And Development Process

The world is very interested in generative artificial intelligence (GAI), and for good reason. People have a better idea of what AI can do...

AI In Drug Development: Calls For Straightforward Regulation

A full-day training called Artificial Intelligence in Drug and Biological Product Development was held on August 6, 2024, by the Food and Drug Administration...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...